Join Us in Person for This ASHP CE Opportunity!

The Whole Kidney and Caboodle: Incorporating Guideline-Based Recommendations to Identify and Manage Chronic Kidney Disease and Reduce Cardiovascular Risks

Most patients with chronic kidney disease (CKD) are unaware they have it. Guidelines have established well-known risk factors for CKD to help identify and screen patients, but many patients remain unscreened and untreated, leading to kidney disease progression, cardiovascular disease, morbidity, and mortality. As the most accessible healthcare professionals, pharmacists are uniquely positioned to identify and screen patients at risk for CKD. Pharmacists can apply guideline recommendations to provide holistic care and improve outcomes and reduce cardiovascular risks for patients with CKD. This educational activity will discuss the cardiovascular risks of CKD and approaches to identifying and screening patients at risk of CKD. This activity will also provide strategies to implement guideline-recommended care of CKD and provide real-world examples of best practices in multidisciplinary care and patient education to equip and inspire pharmacists to bridge gaps across the cardiovascular-kidney-metabolic spectrum. 

Friday, Mar. 13

9:30 a.m.–10:30 a.m. ET

Presentation Location: James River Ballroom, Kingsmill Resort, Williamsburg, Virginia

Featuring...

  Katie Cardone

PharmD, BCACP, FNKF, FASN, FCCP

 Professor and Chair, Department of Pharmacy Practice
Albany College of Pharmacy and Health Sciences
Albany, New York

Target Audience

This activity was planned to meet the educational needs of pharmacists who practice in hospitals, health systems, community pharmacies, and ambulatory clinics who care for or are interested in the care of patients with chronic kidney disease.

Learning Objectives

• Apply guideline-based screening for patients with risk factors for CKD to provide early identification and treatment to reduce the risk of kidney disease progression and adverse cardiovascular outcomes. 
• Analyze guideline-based recommendations and clinical evidence for current and emerging therapies for reducing the risks of CKD progression and cardiovascular risks.
• Identify opportunities within healthcare systems to bridge care and provide holistic, individualized care for people at risk of or with CKM syndrome.

Agenda

9:30 a.m. – Welcome and Introductions
Katie Cardone

9:35 a.m. – Patient Identification and Guideline Recommended Screening for CKD

Katie Cardone

9:50 a.m. – Simplifying the Guidelines and Clinical Evidence to Provide Appropriate Care for Patients with CKD

Katie Cardone

10:15 a.m. – Interprofessional and Holistic Care in CKM Syndrome

Katie Cardone

10:25 a.m. – Faculty Discussion, Questions and Answers

Katie Cardone

Accredited for CPE

ACPE #: 0204-0000-26-401-L01-P

CE Credit: 1.0 contact hour (0.10 CEUs)

Activity Type: Application-based

Activity Fee: No charge 

To Claim CE for the presentation, enter the CE code announced during the activity and complete the evaluation.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Provided by ASHP.
Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
For questions and assistance to participate, contact us.